(ATN) Flu Season Warning

DonateNow
Print this article

(ATN) Flu Season Warning

AIDS TREATMENT NEWS Issue # 185, October 15, 1993
Dave Gilden


This winter's flu season is likely to be particularly severe, the U.S. Public Health Service warns. Three to five times the usual 10,000 to 20,000 flu-related deaths may occur. Worse yet, the harsh "Beijing" strain of influenza that first appeared in February mutated at the end of last year's flu season, and no one is immune to it unless they came down with flu in April or May.

The U.S. Public Health Service is recommending that all persons at special risk for flu complications get the updated version of the flu vaccine by November 15. Among these "at risk" groups are people with HIV. A poster presentation (#2249) at Berlin's International Conference on AIDS found that flu vaccine coverage in the U.S. is "sub optimal," with only about a third of people with HIV receiving the vaccine. Also in Berlin, three posters described a low response rate to the vaccine, especially among people with greatly reduced helper T-cell counts (posters 500, 1264 and 1276).

Stephen Follansbee, M.D., a San Francisco AIDS specialist who is following the issue, nevertheless urges anyone with HIV to be vaccinated. Complications from infection with the influenza virus include bacterial pneumonia, which can be fatal. For people with low T-helper cell counts, Dr. Follansbee suggests that all housemates also have themselves vaccinated. This would create a kind of sanitary wall around the person most in danger.

However, those with a history of allergic reactions to flu shots or to eggs should not be inoculated; and those with fevers should wait until the fevers subside. The vaccine consists of killed influenza virus that was grown in egg cells.

Two posters (209, 1929) in Berlin also dealt with the question of whether flu vaccination increases the level of HIV in the body, due to the immune stimulation the inoculant provokes. Increased HIV replication might spark a further decline in the immune system.

One of the posters said the vaccine does increase viral load for several months; the other found no change. To look at the question further, Dr. Follansbee and a group of associates are planning a short, 30-person trial involving HIV-infected volunteers at different helper T-cell counts. HIV levels and immune function will be measured for 28 days after vaccination.

The trial is now completely enrolled, and a full analysis of the data will not be completed until December at the earliest, well after the recommended vaccination period is over. But Dr. Follansbee says, "I don't want the study to undermine people getting shots." Any negative effect of the flu vaccine is probably minor, compared to the damage the flu could cause.


931015
ATN18503


Copyright © 1993 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .